Pillstats
Rx only · Injection · Intramuscular

Meperidine Hydrochloride

Meperidine Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN02AB02
RxCUI (US)6754
US makers1 labelers
Packages3
DEA / ScheduleCII

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.4K2.8K4.2K5.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.9K
Rx · 2026 Q1
7.5K
Units dispensed
-62%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hikma Pharmaceuticals USA Inc.unknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 30, 2025
    SHORTAGEDrug shortage: Meperidine Hydrochloride Injection (Hikma Pharmaceuticals USA, Inc.)

    Meperidine Hydrochloride Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.